Total Voting Rights

RNS Number : 5408Q

GlaxoSmithKline PLC

01 September 2014

 



GlaxoSmithKline plc

Total Voting Rights and Capital

In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the Company) hereby notifies the market of the following:

The Company's issued share capital as at 31 August 2014 consisted of 5,351,778,639 Ordinary Shares of 25p each, of which 502,139,179 Ordinary Shares were held in Treasury.

Therefore, the total number of voting rights in the Company is 4,849,639,460. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

V A Whyte

Company Secretary

1 September 2014

 

END

 

 

TVRUGUAPBUPCGCG